Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 136
- Adult-Use
Global Cannabis Stocks Significantly Underperformed In 2022, But Trend Expected To ‘Reverse’ In Near Future
THE global cannabis industry’s stocks have performed far worse than the general markets throughout 2022, with nearly US$30bn wiped off the value of the world’s largest 20 cannabis companies.
- Adult-Use
Swiss Cannabis Company Takes Stake In Leading Belgian Wholesaler, Secures Supply Agreement
The Swiss based Cannabis company Astrasana Holding AG with entities in the Czech Republic, Germany and Japan, has agreed a minority acquisition deal on a 2.5M EUR valuation with Belgian cannabis products market leader DLH/Nexgen.
- Medical
UK Cannabis Groups Bring Their Calls For Reform To The Heart Of Government
LAST week saw two leading UK cannabis organisations gather in the Houses of Parliament as both sought to bring their calls for regulatory reform to the heart of government.
- Markets & Stocks
Cannovum To Launch Secondary Listing, Panaxia Signals Exit From Cannabis & Yooma Wellness Revenues Drop
Cannovum German cannabis operator Cannovum announced this week that it was moving its shares onto the ‘Primärmarkt’ (Primary Market) of the Düsseldorf Stock Exchange.
- Medical
MHRA’s New Guidance Points To A ‘Truly Pharmaceutical Path’ For UK Medical Cannabis And Could See End To ‘GACP To GMP Washing’
THE UK’s Medicines and Healthcare products Regulatory Agency (MHRA) last week released new detailed guidelines for medical cannabis companies operating in the UK.
- Adult-Use
As Its Neighbours Seek Legalisation, Poland’s Medical Cannabis & Hemp Industry Could Also Flourish Next Year
EARLIER this month Czechia’s drug commissioner Jindřich Vobořil announced his intention to submit draft legislation for an adult-use cannabis market by the end of the year, hoping a fully fledged market could be launched by 2024.
- Markets & Stocks
Akanda Pulls Out Of Lesotho Amid Ongoing Legal Battle, Bruce Linton Joins SynBiotic, & Ananda Completes Acquisition
Akanda The NASDAQ-listed international medical cannabis operator announced last week that it will abandon its operations in Lesotho following a legal battle with a disgruntled former director.
- News
Amsterdam Cannabis Expo 2022 Latest Scam To Target Industry
AN upcoming European cannabis conference, at which 10,000 cannabis companies were purportedly due to visit, is thought to be the latest scam to target the industry.
- Companies
Juicy Fields Scam May Have Been Small Part Of A Much Larger Criminal Enterprise Says Lawyer As He Prepares To Make Evidence Public
JUICY Fields has already been called the biggest scam in Europe for ‘many, many years’, and its impact on the world of cannabis and cryptocurrency has been such that a number of documentaries are understood to be exploring the case.
- Markets & Stocks
European Cannabis Stocks Review: InterCure Up 10% Amid More Record Results, Stenocare Secures New Funding, & More From Goodbody Health
InterCure InterCure saw its stock jump nearly 10% after releasing its third quarter financial results on Tuesday, November 15.
- CBD Market
EIHA Responds To Criticisms Over Its Novel Food Applications & Tox Studies
THE European Industrial Hemp Association (EIHA) has responded to a number of criticisms from within the industry surrounding its Novel Foods toxicological studies.
- Adult-Use
Cantourage’s €80m Listing Sees Its Share Price Skyrocket 300%
CANTOURAGE has become the third and largest major European medical cannabis operator to go public this year, as investment confidence in the cannabis sector shows further signs of recovery.












